Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
5
×
detroit top stories
indiana blog main
indiana top stories
life sciences
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
clinical trials
deals
aducanumab
biotech
celgene
johnson & johnson
nonalcoholic steatohepatitis
pfizer
abbvie
affordable care act
alzheimer's disease
bayer
biogen
What
bio
drug
5
×
news
5
×
roundup
nash
approved
biogen
biogen’s
companies
fda
help
road
week
adu
aducanumab
alzheimer’s
amyloid
angst
approval
aren’t
bagged
beats
bids
billions
biopharmaceutical
brammer
complicated
convo
depression
developers
digital
dire
disease
drugs
earlier
effects
epidemic
failure
failures
fatty
Language
Current search:
drug
×
" detroit blog main "
×
" life sciences "
×
news
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
6 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More